Hereditary Sideroblastic Anemias: Pathophysiology, Diagnosis, and Treatment

Clara Camaschella

Research output: Contribution to journalArticlepeer-review


Inherited sideroblastic anemia comprises several rare anemias due to heterogeneous genetic lesions, all characterized by the presence of ringed sideroblasts in the bone marrow. This morphological aspect reflects abnormal mitochondrial iron utilization by the erythroid precursors. The most common X-linked sideroblastic anemia (XLSA), due to mutations of the first enzyme of the heme synthetic pathway, delta-aminolevulinic acid synthase 2 (ALAS2), has linked heme deficiency to mitochondrial iron accumulation. The identification of other genes, such as adenosine triphosphate (ATP) binding cassette B7 (ABCB7) and glutaredoxin 5 (GLRX5), has strengthened the role of iron sulfur cluster biogenesis in sideroblast formation and revealed a complex interplay between pathways of mitochondrial iron utilization and cytosolic iron sensing by the iron-regulatory proteins (IRPs). As recently occurred with the discovery of the SLC25A38-related sideroblastic anemia, the identification of the genes responsible for as yet uncharacterized forms will provide further insights into mitochondrial iron metabolism of erythroid cells and the pathophysiology of sideroblastic anemia.

Original languageEnglish
Pages (from-to)371-377
Number of pages7
JournalSeminars in Hematology
Issue number4
Publication statusPublished - Oct 2009

ASJC Scopus subject areas

  • Hematology


Dive into the research topics of 'Hereditary Sideroblastic Anemias: Pathophysiology, Diagnosis, and Treatment'. Together they form a unique fingerprint.

Cite this